HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg Heilmann Selected Research

xanthohumol

2/2013Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury.
1/2012Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis.
7/2010Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.
7/2010Xanthohumol feeding does not impair organ function and homoeostasis in mice.
2/2010Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
10/2009Antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jörg Heilmann Research Topics

Disease

6Neoplasms (Cancer)
10/2012 - 04/2002
4Fibrosis (Cirrhosis)
04/2012 - 07/2010
3Alzheimer Disease (Alzheimer's Disease)
04/2016 - 08/2007
3Body Weight (Weight, Body)
02/2013 - 07/2010
3Inflammation (Inflammations)
01/2012 - 07/2010
2Cognitive Dysfunction
03/2016 - 06/2012
2Ischemia
02/2013 - 10/2009
2Hepatocellular Carcinoma (Hepatoma)
10/2012 - 02/2010
2Necrosis
01/2012 - 03/2005
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2020
1Candidemia
01/2020
1Fever (Fevers)
04/2019
1Headache (Headaches)
04/2019
1Pain (Aches)
04/2019
1Low Back Pain (Lumbago)
04/2019
1Dehydration (Water Stress)
01/2016
1Liver Diseases (Liver Disease)
04/2012
1Non-alcoholic Fatty Liver Disease
01/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2012
1Neurobehavioral Manifestations
05/2010
1Reperfusion Injury
10/2009

Drug/Important Bio-Agent (IBA)

6xanthohumolIBA
02/2013 - 10/2009
3ButyrylcholinesteraseIBA
04/2016 - 05/2010
2AntioxidantsIBA
04/2016 - 10/2009
2AcidsIBA
10/2012 - 04/2012
2Biological ProductsIBA
10/2012 - 10/2009
2Plant ExtractsIBA
06/2010 - 08/2007
2LactonesIBA
05/2003 - 04/2002
2SesquiterpenesIBA
05/2003 - 04/2002
1myrrh resin (myrrh)IBA
11/2020
1Charcoal (Charbon)IBA
11/2020
1CoffeeFDA Link
11/2020
1AzolesIBA
01/2020
1EchinocandinsIBA
01/2020
1willow bark extractIBA
04/2019
1Pharmaceutical PreparationsIBA
04/2019
1isosilybin AIBA
01/2016
1hydnocarpinIBA
01/2016
1silychristinIBA
01/2016
1Silybin (Lagosa)IBA
01/2016
1FlavonolignansIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2013
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2012
1Tacrine (Cognex)FDA Link
06/2012
1Scopolamine (Hyoscine)FDA Link
06/2012
1Transaminases (Aminotransferases)IBA
01/2012
1CytokinesIBA
01/2012
1AcetylcholinesteraseIBA
05/2010
1Cholinergic Agents (Cholinergics)IBA
05/2010
1Chalcone (Benzalacetophenone)IBA
02/2010
1Interleukin-8 (Interleukin 8)IBA
02/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009
1NF-kappa B (NF-kB)IBA
10/2009
1Protein AggregatesIBA
08/2007
1Amyloid beta-PeptidesIBA
08/2007
1PterocarpansIBA
03/2005
1ethyl acetateIBA
03/2005
1naphthaIBA
03/2005
1erybraedin CIBA
03/2005
1IsoflavonesIBA
03/2005

Therapy/Procedure

4Therapeutics
11/2020 - 05/2010
1Transplantation
02/2013